After a comprehensive analysis of the expression data from TCGA, GTEx, and Oncomine databases, we found that Siglec15 was highly expressed in the majority of cancers such as BLCA and breast cancer (BRCA) compared with normal tissues (Figure S1A-D). Here, SIGLEC15 is linked to breast cancer.